Prognostic Value of Histologic Tumor Regression, Thymidylate Synthase, Thymidine Phosphorylase, and Dihydropyrimidine Dehydrogenase in Rectal Cancer UICC Stage II/III After Neoadjuvant Chemoradiotherapy-Reference-Cited by-同舟云学术

Prognostic Value of Histologic Tumor Regression, Thymidylate Synthase, Thymidine Phosphorylase, and Dihydropyrimidine Dehydrogenase in Rectal Cancer UICC Stage II/III After Neoadjuvant Chemoradiotherapy

Published:2006-09 Issue: Volume: Page:1169-1174
ISSN:0147-5185
Container-title:The American Journal of Surgical Pathology
language:en
Short-container-title:The American Journal of Surgical Pathology

Author:

Jakob Christiane,Liersch Torsten,Meyer Wolfdietrich,Baretton Gustavo B.,Schwabe Wolfgang,H??usler Peter,Kulle Bettina,Becker Heinz,Aust Daniela E.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pathology and Forensic Medicine,Surgery,Anatomy

Reference22 articles.

1. Local recurrence of colorectal cancer: The problem, mechanisms, management and adjuvant therapy

2. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction

3. Response to preoperative chemoradiation increases the use of sphincter-preserving surgery in patients with locally advanced low rectal carcinoma

4. Pathological features of rectal cancer after preoperative radiochemotherapy

5. Usefulness of endorectal ultrasound after preoperative radiotherapy in rectal cancer

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathological Tumor Regression Grade Classifications in Gastrointestinal Cancers: Role on Patients’ Prognosis;International Journal of Surgical Pathology;2019-08-16

2. COLON AND RECTAL CANCER ARE DIFFERENT TUMOR ENTITIES ACCORDING TO EPIDEMIOLOGY, CARCINOGENESIS, MOLECULAR- AND TUMOR BIOLOGY, PRIMARY AND SECONDARY PREVENTION: PRECLINICAL EVIDENCE;Siberian journal of oncology;2018-09-04

3. Are Colon and Rectal Cancer Two Different Tumor Entities? A Proposal to Abandon the Term Colorectal Cancer;International Journal of Molecular Sciences;2018-08-30

4. Neoadjuvant radiochemotherapy decreases the total amount of tumor infiltrating lymphocytes, but increases the number of CD8+/Granzyme B+ (GrzB) cytotoxic T-cells in rectal cancer;OncoImmunology;2017-11-07

5. Transcriptional profiles underpin microsatellite status and associated features in colon cancer;Gene;2015-10